Shire Share Price (SHP)

0.00 0.00 (0.00%) delayed: 2:17AM BST
Bid price 4,442.50 Open price 0.00
Ask price 4,443.00 Prev close 4,443.00
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Shire share prices, Shire stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Shire Level 2 Data, indepth research tools and investor commentary for Shire (SHP) and other London Stock Exchange equities.

Shire Share Price Chart

Advanced Charts >>

Register now for FREE Shire share price charts

Shire Share Price Information

Name Shire Epic SHP
Sector Pharmaceuticals & Biotechnology ISIN JE00B2QKY057
Activites Shire plc (formerly Shire Pharmaceuticals Group plc) is the leading global biotechnology company focused on serving people with rare diseases. It strives to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Immunology, Hereditary Angioedema, Hematology, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine, Ophthalmics, a growing franchise in Oncology, and Neuroscience. Index FTSE 100

Shire Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 45.91
Market Capitalisation (£m) 40,462.16 Gross Gearing (%) 46.61
Shares in issue (m) 914.40 Debt Ratio 39.58
P/E Ratio 9.40 Debt-to-Equity Ratio 0.75
Total dividends per share (p) 25.31 Assets / Equity Ratio 1.87
Dividend Yield (%) 0.37 Price to book value 1.12
Dividend cover (x) 18.31 ROCE (%) 3.16
Earning per share (p) 471.00 EPS Growth (%) 995.35
52 week high / low 4,514.50 / 2,940.50 DPS Growth (%) 4.80

Shire Director Deals

Dec.Date Type Director Pos No. of Shares
03/04/2018 BUY Bill Burns NED 187
03/04/2018 BUY Anne Minto NED 184
03/04/2018 BUY Dominic Blakemore NED 184
03/04/2018 BUY Olivier Bohoun NED 163
19/03/2018 BUY Thomas Dittrich ED 9,400

More Shire Director Deals >>

Shire Company News

15:33 16/08/2018

Form 8.5 (EPT/NON-RI)

RNS Number : 0738Y Citigroup Global Markets Inc. 16 August 2018     FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)...

15:20 16/08/2018

Form 8.3 - Shire plc

RNS Number : 0672Y BlackRock Group 16 August 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 4. (c) Supplemental...

15:03 16/08/2018

Form 8.3 - Shire plc

RNS Number : 0703Y FIL Limited 16 August 2018                                                                                                            FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT...

More Shire Company News >>

Register now for FREE Shire company news

Shire Share Price Discussions

3 months ago

class pharma company - slipped under the radar (SHP)

why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall, and...

more than 1 year ago

class pharma company - slipped under the radar (SHP)

why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall, and...

more than 1 year ago

Shire in drug refusal rumours (shp)

There is no smoke without fire, and keen eyed observers will note that Shire Pharmaceutical s is down 7.7% this morning at 372p, having been 13% down at one point. The word in the market is that its application to the US FDA for approval of its Adderall XR treatment for Attention Deficit...

Register now for FREE Shire share price discussions